Literature DB >> 12552470

Do vascular surgery patients need a cardiology work-up? A review of pre-operative cardiac clearance guidelines in vascular surgery.

Farshad Abir1, Iannis Kakisis, Bauer Sumpio.   

Abstract

OBJECTIVES: to outline the appropriate pre-operative cardiac work-up for patients who are scheduled for major peripheral vascular surgery.
DESIGN: review of the literature.
MATERIALS AND METHODS: a review of the literature focusing on studies that have correlated the pre-operative cardiac work-up patients receive to the cardiac morbidity and mortality following vascular surgery. Only studies with level A evidence were included.
RESULTS: peri-operative beta blockade has been shown to decrease cardiac complications after vascular surgery in all risk groups. Non-invasive cardiac testing is only necessary for patients in the intermediate/high risk group. Coronary revascularization should only be considered after a positive non-invasive cardiac test.
CONCLUSIONS: patients must be risk stratified pre-operatively based on history and physical examination. Low risk patients should receive peri-operative beta blockade only with no further non-invasive testing. On the other hand, intermediate and high risk patients should undergo non-invasive cardiac testing before going to the operating room.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12552470     DOI: 10.1053/ejvs.2002.1797

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  3 in total

Review 1.  Non-cardiac vascular disease.

Authors:  Thomas W G Carrell; John H N Wolfe
Journal:  Heart       Date:  2005-02       Impact factor: 5.994

Review 2.  Korean guidelines for the appropriate use of cardiac CT.

Authors:  Young Jin Kim; Hwan Seok Yong; Sung Mok Kim; Jeong A Kim; Dong Hyun Yang; Yoo Jin Hong
Journal:  Korean J Radiol       Date:  2015-02-27       Impact factor: 3.500

Review 3.  Frailty In Patients Undergoing Vascular Surgery: A Narrative Review Of Current Evidence.

Authors:  Nikoletta Rahel Czobor; Jean-Jacques Lehot; Eniko Holndonner-Kirst; Phillip J Tully; Janos Gal; Andrea Szekely
Journal:  Ther Clin Risk Manag       Date:  2019-10-17       Impact factor: 2.423

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.